Literature DB >> 25684983

In 2124, half of all men can count on developing prostate cancer.

P A Pollock1, A Ludgate2, R J Wassersug3.   

Abstract

Entities:  

Year:  2015        PMID： 25684983      PMCID： PMC4324338          DOI： 10.3747/co.22.2102

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  10 in total

1.  Overdiagnosis and overtreatment in cancer: an opportunity for improvement.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid
Journal:  JAMA       Date:  2013-08-28       Impact factor: 56.272

2.  Cases of Fungus Hæmatodes, with Observations, by George Langstaff, Esq. and an Appendix, containing two cases of Analogous Affections.

Authors:  W Lawrence
Journal:  Med Chir Trans       Date:  1817

3.  Recommendations on screening for prostate cancer with the prostate-specific antigen test.

Authors:  Neil Bell; Sarah Connor Gorber; Amanda Shane; Michel Joffres; Harminder Singh; James Dickinson; Elizabeth Shaw; Lesley Dunfield; Marcello Tonelli
Journal:  CMAJ       Date:  2014-10-27       Impact factor: 8.262

4.  Factors influencing patients' acceptance and adherence to active surveillance.

Authors:  David F Penson
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

5.  Quality-of-life effects of prostate-specific antigen screening.

Authors:  Eveline A M Heijnsdijk; Elisabeth M Wever; Anssi Auvinen; Jonas Hugosson; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Arnauld Villers; Alvaro Páez; Sue M Moss; Marco Zappa; Teuvo L J Tammela; Tuukka Mäkinen; Sigrid Carlsson; Ida J Korfage; Marie-Louise Essink-Bot; Suzie J Otto; Gerrit Draisma; Chris H Bangma; Monique J Roobol; Fritz H Schröder; Harry J de Koning
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

6.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

7.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

8.  Quality of life and satisfaction with outcome among prostate-cancer survivors.

Authors:  Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

9.  Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

Authors:  Joshua A Cohn; Chihsiung E Wang; Justin C Lakeman; Jonathan C Silverstein; Charles B Brendler; Kristian R Novakovic; Michael S McGuire; Brian T Helfand
Journal:  Urol Oncol       Date:  2013-08-02       Impact factor: 3.498

10.  Risk communication and prostate cancer: identifying which summary statistics are best understood by men.

Authors:  Dragan Ilic; Kerry Murphy; Sally Green
Journal:  Am J Mens Health       Date:  2012-07-12
  10 in total
  6 in total

1.  Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core.

Authors:  Tomas Bertok; Lenka Lorencova; Stefania Hroncekova; Veronika Gajdosova; Eduard Jane; Michal Hires; Peter Kasak; Ondrej Kaman; Roman Sokol; Vladimir Bella; Anita Andicsova Eckstein; Jaroslav Mosnacek; Alica Vikartovska; Jan Tkac
Journal:  Biosens Bioelectron       Date:  2019-02-01       Impact factor: 12.545

Review 2.  Emerging proteomics biomarkers and prostate cancer burden in Africa.

Authors:  Henry A Adeola; Jonathan M Blackburn; Timothy R Rebbeck; Luiz F Zerbini
Journal:  Oncotarget       Date:  2017-06-06

Review 3.  Cancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers.

Authors:  Prakash Kulkarni; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2017-03-31       Impact factor: 5.923

4.  STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells.

Authors:  Stephanie E A Burnell; Samantha Spencer-Harty; Suzie Howarth; Owen Bodger; Howard Kynaston; Claire Morgan; Shareen H Doak
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

5.  Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer.

Authors:  Stephanie E A Burnell; Samantha Spencer-Harty; Suzie Howarth; Owen Bodger; Howard Kynaston; Claire Morgan; Shareen H Doak
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

6.  Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer.

Authors:  Marcello Serra; Gianluca Ametrano; Valentina Borzillo; Maria Quarto; Matteo Muto; Rossella Di Franco; Savino Federica; Filomena Loffredo; Muto Paolo
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.